Plant cell factories and mucosal vaccines

Amanda M. Walmsley, Charles J. Arntzen

Research output: Contribution to journalReview article

92 Scopus citations

Abstract

Many advances continue to be made in the field of plant-derived vaccines. Plants have been shown capable of expressing a multicomponent vaccine that when orally delivered induces a T-helper cell subset 1 response and enables passive immunization. Furthermore, a plant-derived vaccine has been shown to protect against challenge in the target host. Increased antigen expression levels (up to 4.1% total soluble protein) have been obtained through transformation of the chloroplast genome. In view of these findings, plant-derived vaccines have been proved as valuable commodities to the world's health system; however, before their application, studies need to focus on optimization of immunization strategies and to investigate antigen stability.

Original languageEnglish (US)
Pages (from-to)145-150
Number of pages6
JournalCurrent Opinion in Biotechnology
Volume14
Issue number2
DOIs
StatePublished - Apr 2003

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Plant cell factories and mucosal vaccines'. Together they form a unique fingerprint.

  • Cite this